Decriminalization won’t solve Canada’s drug crisis
Doomed without a long-term, well-funded strategy
Doomed without a long-term, well-funded strategy
Could impact coverage quality for majority of Canadians
Federal government faces pressure to rethink its policies
Rise of weight-loss medications leading to drops in share prices
Patented Medicine Price Review Board hearings show public pharmacare is the strongest option
Current guidelines to determine which patients are at higher risk don’t catch everyone
New drug price guidelines will hinder Canadians access to new and innovative treatments
Today we are joined by Jason Reposa, the founder and CEO of Good Feels, a licensed cannabis operator in Massachusetts
The drugs target an enzyme involved in lowering blood sugar
Today we’re joined by Derek Spruill, co-founder and director of sales for Cherry Blossom Hemp
BudSense takes the pain out of manually creating store menus and tracking inventory
Model predicted high-risk patients with an accuracy of 86 per cent
Drug overdose deaths approaching 2,000 annually